コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 698 outcomes of >/= 30% decline in estimated glomerular filtration rate.
2 for age, sex, body mass index, and estimated glomerular filtration rate.
3 expression, which correlated with declining glomerular filtration rate.
4 and renal function, as assessed by estimated glomerular filtration rate.
5 ts and sudden death in patients with reduced glomerular filtration rate.
6 atified by HbA1c, BMI, region, and estimated glomerular filtration rate.
7 l function, regardless of baseline estimated glomerular filtration rate.
8 e drugs modified according to bodyweight and glomerular filtration rate.
9 topathies and its expression correlates with glomerular filtration rate.
10 oking, elevated triglycerides, and estimated glomerular filtration rate.
11 , including the entire spectrum of estimated glomerular filtration rates.
12 LK and LAT patients had comparable estimated glomerular filtration rates.
13 tinine clearance (median change in estimated glomerular filtration rate -1.8 mL/min [IQR -7.8 to 6.0]
14 0.80; interquartile range, 0.70-1.01 mg/dL; glomerular filtration rate, 102+/-23; median, 106; inter
15 outpatients with type 2 diabetes (estimated glomerular filtration rate, 15 to <60 mL/min/1.73 m2 and
16 ut cirrhosis and with CKD stage 4 (estimated glomerular filtration rate, 15-30 mL/min/1.73 m(2)) or s
17 +/-0.7 vs. 1.0+/-0.9; P=0.003) and estimated glomerular filtration rate (49.5+/-17.4 vs. 60.6+/-19.1
18 all, 1461 (10%) had CKD (mean [SD] estimated glomerular filtration rate, 49 [10] mL/min/1.73 m2).
19 oup had the highest average 1-year estimated glomerular filtration rate (62 mL/min/1.73 kg/m(2)) and
20 sma glucose, high total cholesterol, and low glomerular filtration rate; 72.4%, 95% UI 70.2-73.5) and
21 censored for primary nonfunction, estimated glomerular filtration rates after 1 year and 5 years wer
22 showed a 1.5-fold higher level of estimated glomerular filtration rate and a fourfold lower level of
27 ransplant outcomes included 1-year estimated glomerular filtration rate and death-censored graft surv
28 f >50% reduction in their baseline estimated glomerular filtration rate and end stage kidney disease
35 rimary care, serum creatinine with estimated glomerular filtration rate and proteinuria measurements
36 an arterial pressure was 15 mm Hg higher and glomerular filtration rate and renal blood flow were app
37 proximately 17 mm Hg in both groups, whereas glomerular filtration rate and renal blood flow were dec
38 rogressive reduction in renal blood flow and glomerular filtration rate and showed evidence of renal
39 nificant association between eGFR (estimated glomerular filtration rate) and serum sclerostin levels
40 (n = 50) matched for age, sex, and estimated glomerular filtration rate, and 23 renal transplant reci
41 term follow-up, 1 had a normalized estimated glomerular filtration rate, and 3 (4%) had persistent CK
42 contrast, blood pressure lowering, estimated glomerular filtration rate, and albuminuric effects are
43 d urea nitrogen, serum creatinine, estimated glomerular filtration rate, and blood chemistry variable
44 10) who were matched for age, sex, estimated glomerular filtration rate, and date of MR imaging exami
45 ment should have serum creatinine, estimated glomerular filtration rate, and electrolytes measurement
46 nger, with higher body mass index, estimated glomerular filtration rate, and forced expiratory volume
47 but a higher rate of porcelain aorta, lower glomerular filtration rate, and higher mean Society of T
48 Patients with lower blood pressure, lower glomerular filtration rate, and more severe heart failur
49 fibroblast growth factor 23 level, estimated glomerular filtration rate, and proteinuria, the hazard
51 ni-x and sham sheep, mean arterial pressure, glomerular filtration rate, and renal blood flow were me
52 ulatory support, natriuretic peptide decile, glomerular filtration rate, and total bilirubin level we
53 urinary protein, serum creatinine, estimated glomerular filtration rate, and/or pyuria were correlate
54 omparable serum creatinine levels, estimated glomerular filtration rates, and daily urine output at d
55 h-density lipoprotein cholesterol, estimated glomerular filtration rate, antihypertensive therapy, di
56 function imaging, where blood velocities and glomerular filtration rates are simultaneously measured,
57 ents on belatacept has demonstrated superior glomerular filtration rates as compared with CNIs, albei
58 llograft fibrosis and with reduced estimated glomerular filtration rate at 12 months after transplant
59 t function had significantly lower estimated glomerular filtration rate at 12 months postbiopsy and a
61 The changes in serum potassium and estimated glomerular filtration rate at 24, 48, 72, and 96 hours.
63 ave significantly reduced graft survival and glomerular filtration rate at 5 years, especially TMA.
66 atients had significantly worse (P < 0.0001) glomerular filtration rates at 1, 2, 3, and 4 years post
70 al function decline (>20% decrease estimated glomerular filtration rate between 6 months and last fol
71 and 30, there was no difference in estimated glomerular filtration rate between the RF study group an
72 ons in dietary Na(+) intake do not alter the glomerular filtration rate but alter the total and cell-
73 acute, dose-dependent reduction in estimated glomerular filtration rate by approximately 5 mL.min(-1)
74 , respectively) and similar across estimated glomerular filtration rate categories but was significan
76 ession, administration of SRT3025 attenuated glomerular filtration rate decline and proteinuria witho
78 ysis, transplantation, and/or >60% estimated glomerular filtration rate decline, or mortality) outcom
79 ndomization to month 36, mean (SD) estimated glomerular filtration rate decreased by 7.0 (31.3) mL/mi
82 of lithium maintenance therapy on estimated glomerular filtration rate (eFGR) in patients with affec
83 tinine ratio >/=300 mg/g), reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2), an
84 lished cardiovascular disease, and estimated glomerular filtration rate (eGFR) >/=30 mL.min(-1).1.73
85 D Among 3 570 865 US veterans with estimated glomerular filtration rate (eGFR) >/=60 mL min(-1) 1.73
86 served kidney function (defined by estimated glomerular filtration rate (eGFR) >60 mL/minute/1.73 m(2
89 I: 1.99-4.80), moderately impaired estimated glomerular filtration rate (eGFR) (HR = 1.76, 95% CI: 1.
90 inine level and cystatin C-derived estimated glomerular filtration rate (eGFR) and assessment of prot
91 e effects of MRP inhibitors on the estimated glomerular filtration rate (eGFR) and proximal tubular f
92 ociated with future decline in the estimated glomerular filtration rate (eGFR) and with incident chro
94 t survival, whereas one-year graft estimated glomerular filtration rate (eGFR) correlated with donor
95 sed to estimate the annual rate of estimated glomerular filtration rate (eGFR) decline, comparing men
97 is of kidney function based on the estimated glomerular filtration rate (eGFR) in 110,517 European an
98 PM2.5 exposure was associated with estimated glomerular filtration rate (eGFR) in a cohort of older m
100 ebrovascular disease and preserved estimated glomerular filtration rate (eGFR) is not established.
102 (stages 3 and 4) was defined as an estimated glomerular filtration rate (eGFR) of 15 to 59 mL/min/1.7
103 compensated cirrhosis, and with an estimated glomerular filtration rate (eGFR) of 40 mL/min or greate
104 compensated cirrhosis, and with an estimated glomerular filtration rate (eGFR) of 40 mL/min or greate
105 6662 participants with a baseline estimated glomerular filtration rate (eGFR) of at least 60 mL/min/
106 oncentrations and risk of incident estimated glomerular filtration rate (eGFR) of less than 60 mL/min
107 patients with a prehospitalization estimated glomerular filtration rate (eGFR) of more than 45 mL/min
108 t of 3,376,187 US veterans with an estimated glomerular filtration rate (eGFR) of more than 60 mL/min
109 etween the AMS and post-transplant estimated glomerular filtration rate (eGFR) using mixed models, co
110 of 6 y, we assessed kidney volume, estimated glomerular filtration rate (eGFR) using serum creatinine
111 166 (73.1%) had diabetes, the mean estimated glomerular filtration rate (eGFR) was 33.9 +/- 15.8 ml/m
114 y the association of pre-operative estimated glomerular filtration rate (eGFR) with PPCs in laparosco
115 ividuals from four ancestries, for estimated glomerular filtration rate (eGFR), a measure of kidney f
116 nal hazard model adjusted for age, estimated glomerular filtration rate (eGFR), and cardiovascular co
117 ion/primary nonfunction (DGF/PNF), estimated glomerular filtration rate (eGFR), and graft-survival at
118 bin, total white cell count (WCC), estimated glomerular filtration rate (eGFR), and liver function en
119 ecipient's SCr and calculations of estimated glomerular filtration rate (eGFR), based on recipient ag
120 enome-wide association studies for estimated glomerular filtration rate (eGFR), combining data across
121 renal outcomes: >/=30% decline in estimated glomerular filtration rate (eGFR), doubling of the serum
122 y function, as measured by reduced estimated glomerular filtration rate (eGFR), has been associated w
123 comes were HbA1c, LDL cholesterol, estimated glomerular filtration rate (eGFR), incident microalbumin
124 inverse correlation between CI and estimated glomerular filtration rate (eGFR), such that higher CI w
126 ) US veterans with normal baseline estimated glomerular filtration rate (eGFR), we examined the assoc
138 nd without hypertension and normal estimated glomerular filtration rates (eGFR) during 2005 and 2006,
139 he absence of diagnostic criteria (estimated glomerular filtration rate [eGFR] >60 ml/min/1.73 m2 and
140 ts with baseline renal impairment (estimated glomerular filtration rate [eGFR] </= 60 mL/min) and pai
141 disease (CKD, defined as confirmed estimated glomerular filtration rate [eGFR] </= 60 ml/min/1.73 m2)
142 ed prevalence of renal impairment (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73m2), al
143 c kidney disease (serum creatinine estimated glomerular filtration rate [eGFR] <90 mL/min/1.73 m2 or
144 easures of chronic kidney disease (estimated glomerular filtration rate [eGFR] and albuminuria) with
145 ed in grams] and a decrease in the estimated glomerular filtration rate [eGFR] of <5 ml per minute pe
146 1-2 chronic kidney disease (CKD) (estimated glomerular filtration rate [eGFR], >/= 60 mL/min/1.73 m(
147 y and postdonation renal function (estimated glomerular filtration rate, eGFR) of the remaining kidne
148 abetes mellitus and inversely with estimated glomerular filtration rate (eGFRcreatcysC)(all P < 0.001
150 gh-sensitivity C-reactive protein, estimated glomerular filtration rate, elevated TMAO levels remaine
151 n should reflect ongoing baseline, discharge glomerular filtration rate estimated from creatinine con
152 when estimated from cystatin C compared with glomerular filtration rate estimated from creatinine, 44
153 atinine consistently overestimated follow-up glomerular filtration rate estimated from creatinine, wh
154 mated from creatinine, whereas ICU discharge glomerular filtration rate estimated from cystatin C wel
157 ificant for death, 25% decrease in estimated glomerular filtration rate from baseline, major adverse
158 (95% CI 0.003-0.02; p < 0.005) in estimated glomerular filtration rate from serum creatinine, 0.01 g
159 acid (PUA) levels are associated with lower glomerular filtration rate (GFR) and higher blood pressu
160 lized changes from baseline in the estimated glomerular filtration rate (GFR) and measured GFR were -
161 as conducted to determine if TRPC6 regulates glomerular filtration rate (GFR) and the contractile fun
162 udy of the effects of dietary salt intake on glomerular filtration rate (GFR) and tubular Na(+) reabs
165 dney volume and the decline in the estimated glomerular filtration rate (GFR) but also caused more el
166 rfiltration is a risk factor for accelerated glomerular filtration rate (GFR) decline and nephropathy
168 plasma flow (RPF), renocortical volume, and glomerular filtration rate (GFR) early after the procedu
169 ch the addition of serum cystatin C improves glomerular filtration rate (GFR) estimation and mortalit
171 nd renal outcome, with a mean improvement in glomerular filtration rate (GFR) of 6.1 mL/min/year amon
172 dition as decreased kidney function shown by glomerular filtration rate (GFR) of less than 60 mL/min
174 late ion transport in response to changes in glomerular filtration rate (GFR) to maintain glomerulotu
175 pulation and determined the best theoretical glomerular filtration rate (GFR) to use in this estimati
179 g measures of pregnancy physiology (albumin, glomerular filtration rate (GFR)), with log-transformed
180 inaccuracy of creatinine-based estimates of glomerular filtration rate (GFR), UK and international g
181 This association could be attributable to glomerular filtration rate (GFR), which is related to PF
188 dney transplantation patients with estimated glomerular filtration rate greater than 90 have worse ou
189 5 525 white patients with baseline estimated glomerular filtration rate >/= 60 mL.min(-)(1).1.73 m(-)
190 percent of the participants had an estimated glomerular filtration rate >30 mL/min per 1.73 m(2).
191 We selected adult subjects with an estimated glomerular filtration rate >60 mL/min/1.73m(2), an outpa
192 ents with normal or impaired renal function (glomerular filtration rate >80 mL/min or between 80 and
193 higher in the presence of a lower estimated glomerular filtration rate, higher albuminuria, hyperten
194 lder age, diabetes mellitus, lower estimated glomerular filtration rate, higher heart rate, prior myo
195 wer systolic blood pressure, lower estimated glomerular filtration rate, higher N-terminal pro-B-type
196 001) or biliary cancer (HR 12.7, P < 0.001), glomerular filtration rate (HR 0.89, P = 0.002), hyperte
197 ould be used for the evaluation of estimated glomerular filtration rate in patients with stabilized s
199 at 3 years posttransplant (loss of estimated glomerular filtration rate in the chemoprophylaxis cohor
200 st histological predictor for posttransplant glomerular filtration rate in the LAT group was the exte
201 olic blood pressure decreased, and estimated glomerular filtration rate increased (P=0.003) more in t
203 rapy discontinuation when baseline estimated glomerular filtration rate is above 44 mL/min/1.73 m.
204 ood pressure, BMI, smoking status, estimated glomerular filtration rate, LDL-cholesterol concentratio
205 ards models adjusted for age, sex, estimated glomerular filtration rate, left ventricular ejection fr
206 holesterol, antihypertensive medication use, glomerular filtration rate, left ventricular mass index,
207 daily blocks walked, diuretic use, estimated glomerular filtration rate, left ventricular mass, eject
209 defined as a return to dialysis or estimated glomerular filtration rate less than 15 mL/min/1.73 m.
210 th end-stage nonrenal disease with estimated glomerular filtration rate less than 30 mL/min per 1.73
212 rtension, 32% had LVH, and 38% had estimated glomerular filtration rate less than 60 mL/min per 1.73
213 discharge, almost twice as many patients had glomerular filtration rate less than 60 mL/min/1.73 m wh
214 0 mg/dL, cystatin C >/=1.11 mg/dL, estimated glomerular filtration rate less than 60 mL/min/1.73 m, a
215 with type 2 diabetes and CKD (with estimated glomerular filtration rate less than 60 mL/min/1.73 m2),
216 onic kidney disease was defined as estimated glomerular filtration rate less than 60 mL/min/1.73 m2,
217 me was incident CKD, defined as an estimated glomerular filtration rate less than 60 mL/min/1.73 m2.
219 , progression of retinopathy, changes in the glomerular filtration rate, lipid levels, and measures o
220 fter adjusting for age, race, sex, estimated glomerular filtration rate, liver volume, and total kidn
221 sidered if chronic kidney disease (estimated glomerular filtration rate < 45 mL/min/1.73 m(2)) or pro
222 ey disease (serum creatinine level >3 mg/dL; glomerular filtration rate <15 mL/min; acute kidney inju
223 , >1 g proteinuria, heart failure, estimated glomerular filtration rate <20 mL.min(-1).1.73 m(-2), or
224 proteinuria daily, heart failure, estimated glomerular filtration rate <20 ml/min/1.73 m(2), or rece
225 se, renal death, development of an estimated glomerular filtration rate <30 mL/min per 1.73m(2), or d
228 oup had borderline renal function (estimated glomerular filtration rate <45 mL/min/1.73 m(2)) and hep
229 ients with chronic kidney disease (estimated glomerular filtration rate <60 mL.min(-1).1.73 m(-2)).
230 ification of Diet in Renal Disease-estimated glomerular filtration rate <60 mL.min(-1).1.73 m(-2)).
231 pants with chronic kidney disease (estimated glomerular filtration rate <60 mL/min per 1.73 m(2) or u
232 ng within 1 year in ACHD included: estimated glomerular filtration rate <60 ml/min/1.73 m(2) (hazard
233 t hoc analysis of subjects with an estimated glomerular filtration rate <60 ml/min/1.73 m(2), a first
234 in patients with RD, defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2), and com
235 pnea, and any of the following: 1) estimated glomerular filtration rate <60 ml/min/1.73 m(2); 2) hypo
236 pants with chronic kidney disease (estimated glomerular filtration rate <60 mL/min/1.73 m2) receiving
237 e main outcome was CKD, defined as estimated glomerular filtration rate <60 mL/minute/1.73 m(2) (usin
240 5-30 mL/min/1.73 m(2)) or stage 5 (estimated glomerular filtration rate, <15 mL/min/1.73 m(2) or requ
241 p in 521 stable subjects with CKD (estimated glomerular filtration rate, <60 mL/min per 1.73 m(2)).
242 itions characterized by a sudden decrease in glomerular filtration rate, manifested by an increase in
244 th active/acute ABMR had a 3-month estimated glomerular filtration rate (median,: 43 mL/min) lower th
246 w-density lipoprotein cholesterol, estimated glomerular filtration rate, metabolic syndrome, and the
249 ssure, lipid profile, retinopathy, estimated glomerular filtration rate, (micro)albuminuria, the use
250 red) renal allograft survival with estimated glomerular filtration rates (mL/min per 1.73 m) of 43 to
251 ction or severe graft dysfunction: estimated glomerular filtration rate (Modification of Diet in Rena
254 l class, diastolic blood pressure, estimated glomerular filtration rate, N-terminal pro-B-type natriu
255 t after 1 January 2007; CKD was defined as a glomerular filtration rate of <60 mL/min/1.73 m(2).
256 history of coronary heart disease, estimated glomerular filtration rate of 20 to 59 ml/min/1.73 m(2),
257 ort study recruited adults with an estimated glomerular filtration rate of 20 to 70 mL/min/1.73 m2 fr
258 inine ratio [UACR] 100-3000 mg/g), estimated glomerular filtration rate of 25 mL/min per 1.73 m(2) or
259 95% CI, 1.05-1.51) and decrease in estimated glomerular filtration rate of 30% or more (11,045 events
261 V-1 RNA <50 copies per mL) with an estimated glomerular filtration rate of 50 mL per min or greater,
263 function was excellent with a mean estimated glomerular filtration rate of 54 mL per min after 1 year
264 e of graft function (difference in estimated glomerular filtration rate of 9.6 mL/min per 1.73 m(2) a
265 those with type 1 diabetes with an estimated glomerular filtration rate of 90 mL/min/1.73 m2 or highe
266 tients with type 2 diabetes and an estimated glomerular filtration rate of at least 30 ml per minute
268 of at least 100 cells per muL, and estimated glomerular filtration rate of at least 90 mL/min per 1.7
269 nts of at least 200 cells per muL, estimated glomerular filtration rates of at least 70 mL per min, a
270 a reduction of 50% or more in the estimated glomerular filtration rate or end-stage graft failure.
271 o significant difference in 1-year estimated glomerular filtration rate or graft failure between grou
272 rhosis and ascites; rifaximin did not affect glomerular filtration rate or levels of vasoactive hormo
273 ompared with those with either low estimated glomerular filtration rate or proteinuria (18.7%) and th
274 ient or graft survival, rejection, estimated glomerular filtration rate, or other adverse events was
275 thickness, other cardiovascular markers, the glomerular filtration rate, or progression of retinopath
276 min creatinine ratio (P < 0.01), the fall in glomerular filtration rate (P < 0.001), and improved ren
278 ysis, serum uric acid (P = 0.001), estimated glomerular filtration rate (P = 0.027), and VCAM (P = 0.
280 ratios; 95% CIs) were age (1.13; 1.06-1.20), glomerular filtration rate per 5-U increments (0.93; 0.9
281 r SD increase; OR, 1.13; 95% CI, 1.05-1.21), glomerular filtration rate (per SD increase; OR, 0.67; 9
284 renal composite (40% reduction in estimated glomerular filtration rate, renal replacement therapy, o
285 YHA functional class (III vs. II), estimated glomerular filtration rate, responders to chemotherapy,
287 f a sustained 40% reduction in the estimated glomerular filtration rate, the need for renal-replaceme
288 .0044), while the routinely used parameters (glomerular filtration rate, urine albumin-to-creatinine
289 7 y, 52% were female, and the mean estimated glomerular filtration rate was 31 +/- 9 mL . min(-1) . 1
290 ncrease in spherical equivalent or estimated glomerular filtration rate was associated with a 0.70-mi
294 treatment, a 16-mL/min decline in estimated glomerular filtration rate was observed in patients from
295 months, a progressively declining estimated glomerular filtration rate was observed more frequently
297 ent's weight, BMI, creatinine, and estimated glomerular filtration rate were 81.9 kg, 35.1 kg/m, 0.79
298 aft and patient survival, and mean estimated glomerular filtration rate were also comparable between
299 mortality, and >/= 30% decline in estimated glomerular filtration rate were examined using Cox propo
300 terstitial inflammation score, and estimated glomerular filtration rate were significantly worse in u
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。